Format: 1-hour Virtual Thought Leadership Session
Date & Time: Wednesday, 11th September, 1:30–2:30 PM BST / 8:30–9:30 AM EST
Platform: Zoom
1:30 PM – Thought Leader Interview (20 mins)
Harnessing Multi-Omics for Next-Generation Drug Discovery
Interview with Tom Lanz, Senior Director of Multi-Omics and Biomarkers, Pfizer
2:00 PM – Panel Discussion (30 mins)
How Multi-Omics is Transforming Drug Development – Key Opportunities & Challenges
Topics to be covered:
- Promising multi-omic combinations (genomics, transcriptomics, proteomics, metabolomics) for target discovery
- Translating omic signals into actionable pathways in early-stage drug development
- Reverse translation work
- Technical barriers: data integration, harmonisation, and computational complexity
- Sample quality: FFPE vs fresh tissue; bulk vs spatial resolution
- Tumour microenvironment (TME) challenges in multi-omic profiling and clinical relevance
Moderator:
Tom Lanz, Senior Director of Multi-Omics and Biomarkers, Pfizer
Panellists:
Sunhwa Kim, Associate Scientific Director, AbbVie
Wei Wang, Director, Genomic Core Facility, Princeton University
Junmin Peng, Professor of Proteomics and Metabolomics, St. Jude Children's Research Hospital
To attend this Thought Leadership session you need to be a Premium LifeScienceXchange member.
Secure all the benefits and sign-up for Premium membership now
*If you’re already a Premium member your exclusive invite will be sent direct to your inbox